Bliss GVS Pharma Ltd
Bliss GVS Pharma Ltd - 506197 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
01 / The disclosure
What the company shared
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Anupam Rasayan India Ltd
A question for your research
Check transaction size, funding, dilution, approvals and completion conditions before assessing the earnings impact.
The evidence
Read the source excerpts
01Subject: DisclosureunderRegulation29(1)oftheSecuritiesandExchangeBoardofIndia (SubstantialAcquisitionofSharesandTakeovers)Regulations,2011(“Takeover Regulations”)
Page 1
02Please find enclosed disclosure under Regulation 29(1) of the Takeover Regulations ( with PAN details) in relation to the acquisition of equity shares of Bliss GVS Pharma Limited by Anupam Rasayan India Limited and Mates Visa Consultancy Private Limited.
Page 1
03Disclosure under Regulation 29(1) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 Part-A- Details of the Acquisition Name of the Target Company (“ TC”) Bliss GVS Pharma Limited Name(s) of the acquirer and Persons Acting in Concert (PAC) with the acquirer Anupam Rasayan India Limited (“Acquirer”) and Mates Visa Consultancy Private Limited (“PAC”) Whether the acquirer belongs to Promoter/Promoter group Yes.
Page 2
04Name(s) of the Stock Exchange(s) where the shares of TC are Listed BSE Limited and the National Stock Exchange of India Limited Details of the acquisition as follows Number % w.r.t.
Page 2
05total diluted share/voti ng capital of the TC (**) Before the acquisition under consideration, holding of acquirer along with PACs of:
Page 2
Source & verificationView the disclosure trail
- Summary method
- Exchange-provided text; no generated financial figures
- Exchange identifier
- 8db9fee9-57f9-43b0-9e68-3dc0b5bbcd34
- First collected
- 3 Oct 2026, 17:18 IST
- PDF extraction
- extracted · 2 pages read
- Extraction note
- Source excerpts; financial tables have not been validated.
- Document SHA-256
- d9dd6254fb8b19dce03582db7776c1d11388882e654dad64abd067898f24abee